Kennedy Capital Management’s ENvue Medical Inc FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-229
Closed -$352K 688
2020
Q3
$352K Buy
229
+56
+32% +$149K 0.01% 609
2020
Q2
$856K Buy
173
+17
+11% +$79.4K 0.02% 586
2020
Q1
$736K Buy
156
+10
+7% +$58.5K 0.03% 586
2019
Q4
$914K Sell
146
-2
-1% -$12.7K 0.02% 621
2019
Q3
$811K Hold
148
0.02% 607
2019
Q2
$941K Hold
148
0.02% 610
2019
Q1
$1.31M Buy
148
+4
+3% +$32.9K 0.03% 586
2018
Q4
$1.15M Buy
144
+1
+0.7% +$8.36K 0.03% 600
2018
Q3
$1.44M Buy
143
+7
+5% +$70.6K 0.03% 613
2018
Q2
$1.44M Buy
136
+18
+15% +$182K 0.03% 637
2018
Q1
$1.23M Buy
118
+22
+23% +$222K 0.02% 651
2017
Q4
$993K Buy
+96
New +$961K 0.02% 671

Other funds holding FEED

Kennedy Capital Management's FEED Position: Q4 2020 in Review

Kennedy Capital Management sold out of ENvue Medical Inc (FEED) in Q4 2020, closing a stake of 229 shares — an estimated $352K sold.

Kennedy Capital Management first reported a position in FEED in Q4 2017 and held it in 12 quarters. The position peaked at $1.44M in Q3 2018. 11 funds tracked by Wall St. Rank hold FEED as of Q4 2020.

  • Kennedy Capital Management reported no remaining ENvue Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 229 ENvue Medical Inc shares in Q4 2020, an estimated $352K.
  • Kennedy Capital Management first reported a position in ENvue Medical Inc in Q4 2017 and held it in 12 quarters.
  • Kennedy Capital Management's ENvue Medical Inc position peaked at $1.44M in Q3 2018.
  • 11 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q4 2020.

Based on Kennedy Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.